MARSHALL TEXAS– California resident Canstanza Raspa claims that her development of breast cancer, resulting surgery and mastectomy are the result of 10 years of hormone replacement therapy.
Raspa filed a product liability suit against hormone replacement manufacturers Wyeth, Pfizer, Pharmacia and Upjohn Inc. on Sept 3, in the Marshall Division of the Eastern District of Texas.
The lawsuit alleges that the defendants are liable for claims of fraudulent concealment, negligence, strict products liability, defective marketing, in adequate warnings, negligent misrepresentations, fraud, and breach of express warranty.
The drugs’ manufacturers are involved in many lawsuits regarding hormone replacement drugs, which are marketed to women going through menopause. The companies deny all negligent claims and continuously argue that since first marketing the drugs, they carried warning labels regarding the heightened risk of breast cancer.
The hormone replacement drugs remain FDA-approved for treatment of menopause and post menopausal osteoporosis.
Medical Analysis: Replacement hormone therapy is fraught with danger from side effects including acceleration of cancer, auto immune disease and thromboembolic events such as strokes, vein blood clots and heart attacks. Patients on these drugs need to be clooely monitored for side effects and cancer screening.
Legal Analysis: Tough fight ahead, the drug manufacturers will try and be shielded by the FDA approval as a safe drug.